Absolute Home Health Care | |
8273 South Saginaw Road, Suite A, Grand Blanc, Michigan 48439 | |
(810) 694-1042 | |
Name | Absolute Home Health Care |
---|---|
Location | 8273 South Saginaw Road, Suite A, Grand Blanc, Michigan |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 237732 |
Ownership Type | Proprietary |
Service Area Zip Codes | 48067, 48227, 48307, 48314, 48327, 48329, 48340, 48341, 48346, 48350, 48359, 48362, 48371, 48412, 48415, 48416, 48418, 48420, 48421, 48423, 48426, 48428, 48429, 48430, 48432, 48433, 48435, 48436, 48437, 48438, 48439, 48440, 48442, 48444, 48446, 48449, 48451, 48455, 48457, 48458, 48460, 48461, 48462, 48463, 48464, 48473, 48502, 48503, 48504, 48505, 48506, 48507, 48509, 48519, 48529, 48532, 48601, 48602, 48603, 48609, 48611, 48612, 48613, 48616, 48626, 48631, 48634, 48637, 48638, 48640, 48642, 48650, 48652, 48658, 48659, 48662, 48701, 48706, 48708, 48720, 48722, 48723, 48725, 48727, 48731, 48732, 48734, 48744, 48746, 48747, 48748, 48760, 48767, 48768, 48817, 48858, 48867, 48872 |
NPI Number | 1689729873 |
Organization Name | ABSOLUTE HOME HEALTH CARE, INC. |
Address | 9463 Holly Road, Suite 104, Grand Blanc, MI 48439 |
Phone Number | 810-694-1042 |
News Archive
Medtronic, Inc. today announced that the U.S. Food and Drug Administration (FDA) has informed the company that issues noted in two warning letters - one from November 2009 regarding the company's Mounds View, Minnesota facility and another from June 2009 regarding the company's manufacturing facility in Juncos, Puerto Rico - have been resolved.
Science professionals, doctoral and postdoctoral students from across the country will gather May 20 through 27 at the MDI Biological Laboratory in Bar Harbor, Maine, for an intensive one-week course in Quantitative Fluorescence Microscopy.
Sustaining a traumatic brain injury is associated with an increased risk of developing both dementia and Alzheimer's disease, according to a nationwide study of 2.8 million people over 36 years, published in The Lancet Psychiatry.
Acceleron Pharma Inc., a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today reported that Acceleron, Celgene and investigators in the sotatercept and ACE-536 phase 2 clinical trials will give three oral presentations of interim data from ongoing studies in beta-thalassemia and myelodysplastic syndromes as well as a poster presentation of nonclinical data in sickle cell disease at the 19th Annual Congress of the European Hematology Association (EHA) in Milan, Italy from June 12-15, 2014.
I hadn't expected the tears. My primary care doctor and I were saying goodbye after nearly 30 years together.
› Verified 7 days ago
Quality Rating: |
News Archive
Medtronic, Inc. today announced that the U.S. Food and Drug Administration (FDA) has informed the company that issues noted in two warning letters - one from November 2009 regarding the company's Mounds View, Minnesota facility and another from June 2009 regarding the company's manufacturing facility in Juncos, Puerto Rico - have been resolved.
Science professionals, doctoral and postdoctoral students from across the country will gather May 20 through 27 at the MDI Biological Laboratory in Bar Harbor, Maine, for an intensive one-week course in Quantitative Fluorescence Microscopy.
Sustaining a traumatic brain injury is associated with an increased risk of developing both dementia and Alzheimer's disease, according to a nationwide study of 2.8 million people over 36 years, published in The Lancet Psychiatry.
Acceleron Pharma Inc., a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today reported that Acceleron, Celgene and investigators in the sotatercept and ACE-536 phase 2 clinical trials will give three oral presentations of interim data from ongoing studies in beta-thalassemia and myelodysplastic syndromes as well as a poster presentation of nonclinical data in sickle cell disease at the 19th Annual Congress of the European Hematology Association (EHA) in Milan, Italy from June 12-15, 2014.
I hadn't expected the tears. My primary care doctor and I were saying goodbye after nearly 30 years together.
› Verified 7 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 99.2 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 100 | 98.6 |
How often the home health team checked patients’ risk of falling | 99.9 | 99.6 |
How often the home health team checked patients for depression | 99.5 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 91.5 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 93.8 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 99.6 | 96.4 |
News Archive
Medtronic, Inc. today announced that the U.S. Food and Drug Administration (FDA) has informed the company that issues noted in two warning letters - one from November 2009 regarding the company's Mounds View, Minnesota facility and another from June 2009 regarding the company's manufacturing facility in Juncos, Puerto Rico - have been resolved.
Science professionals, doctoral and postdoctoral students from across the country will gather May 20 through 27 at the MDI Biological Laboratory in Bar Harbor, Maine, for an intensive one-week course in Quantitative Fluorescence Microscopy.
Sustaining a traumatic brain injury is associated with an increased risk of developing both dementia and Alzheimer's disease, according to a nationwide study of 2.8 million people over 36 years, published in The Lancet Psychiatry.
Acceleron Pharma Inc., a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today reported that Acceleron, Celgene and investigators in the sotatercept and ACE-536 phase 2 clinical trials will give three oral presentations of interim data from ongoing studies in beta-thalassemia and myelodysplastic syndromes as well as a poster presentation of nonclinical data in sickle cell disease at the 19th Annual Congress of the European Hematology Association (EHA) in Milan, Italy from June 12-15, 2014.
I hadn't expected the tears. My primary care doctor and I were saying goodbye after nearly 30 years together.
› Verified 7 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 77.4 | 79.6 |
How often patients got better at getting in and out of bed | 89.5 | 81.1 |
How often patients got better at bathing | 82.8 | 82.3 |
How often patients’ breathing improved | 78.5 | 82.8 |
How often patients’ wounds improved or healed after an operation | 95.4 | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 71.2 | 75 |
How often home health patients had to be admitted to the hospital | 15.2 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 10.7 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 96.3 | 94 |
News Archive
Medtronic, Inc. today announced that the U.S. Food and Drug Administration (FDA) has informed the company that issues noted in two warning letters - one from November 2009 regarding the company's Mounds View, Minnesota facility and another from June 2009 regarding the company's manufacturing facility in Juncos, Puerto Rico - have been resolved.
Science professionals, doctoral and postdoctoral students from across the country will gather May 20 through 27 at the MDI Biological Laboratory in Bar Harbor, Maine, for an intensive one-week course in Quantitative Fluorescence Microscopy.
Sustaining a traumatic brain injury is associated with an increased risk of developing both dementia and Alzheimer's disease, according to a nationwide study of 2.8 million people over 36 years, published in The Lancet Psychiatry.
Acceleron Pharma Inc., a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today reported that Acceleron, Celgene and investigators in the sotatercept and ACE-536 phase 2 clinical trials will give three oral presentations of interim data from ongoing studies in beta-thalassemia and myelodysplastic syndromes as well as a poster presentation of nonclinical data in sickle cell disease at the 19th Annual Congress of the European Hematology Association (EHA) in Milan, Italy from June 12-15, 2014.
I hadn't expected the tears. My primary care doctor and I were saying goodbye after nearly 30 years together.
› Verified 7 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | |
Health team communicated well with them | |
Health team discussed medicines, pain, and home safety | |
How patients rated overall care from agency |
News Archive
Medtronic, Inc. today announced that the U.S. Food and Drug Administration (FDA) has informed the company that issues noted in two warning letters - one from November 2009 regarding the company's Mounds View, Minnesota facility and another from June 2009 regarding the company's manufacturing facility in Juncos, Puerto Rico - have been resolved.
Science professionals, doctoral and postdoctoral students from across the country will gather May 20 through 27 at the MDI Biological Laboratory in Bar Harbor, Maine, for an intensive one-week course in Quantitative Fluorescence Microscopy.
Sustaining a traumatic brain injury is associated with an increased risk of developing both dementia and Alzheimer's disease, according to a nationwide study of 2.8 million people over 36 years, published in The Lancet Psychiatry.
Acceleron Pharma Inc., a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today reported that Acceleron, Celgene and investigators in the sotatercept and ACE-536 phase 2 clinical trials will give three oral presentations of interim data from ongoing studies in beta-thalassemia and myelodysplastic syndromes as well as a poster presentation of nonclinical data in sickle cell disease at the 19th Annual Congress of the European Hematology Association (EHA) in Milan, Italy from June 12-15, 2014.
I hadn't expected the tears. My primary care doctor and I were saying goodbye after nearly 30 years together.
› Verified 7 days ago
The patient survey data of Absolute Home Health Care is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 93 | 88 |
Percent of patients who reported that their home health team communicated well with them | 84 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 79 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 88 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 83 | 78 |
News Archive
Medtronic, Inc. today announced that the U.S. Food and Drug Administration (FDA) has informed the company that issues noted in two warning letters - one from November 2009 regarding the company's Mounds View, Minnesota facility and another from June 2009 regarding the company's manufacturing facility in Juncos, Puerto Rico - have been resolved.
Science professionals, doctoral and postdoctoral students from across the country will gather May 20 through 27 at the MDI Biological Laboratory in Bar Harbor, Maine, for an intensive one-week course in Quantitative Fluorescence Microscopy.
Sustaining a traumatic brain injury is associated with an increased risk of developing both dementia and Alzheimer's disease, according to a nationwide study of 2.8 million people over 36 years, published in The Lancet Psychiatry.
Acceleron Pharma Inc., a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today reported that Acceleron, Celgene and investigators in the sotatercept and ACE-536 phase 2 clinical trials will give three oral presentations of interim data from ongoing studies in beta-thalassemia and myelodysplastic syndromes as well as a poster presentation of nonclinical data in sickle cell disease at the 19th Annual Congress of the European Hematology Association (EHA) in Milan, Italy from June 12-15, 2014.
I hadn't expected the tears. My primary care doctor and I were saying goodbye after nearly 30 years together.
› Verified 7 days ago
Ascension At Home Location: 5445 Ali Drive, Dept 200, Grand Blanc, Michigan 48439 Ratings: Phone: (810) 603-8600 | |
Hope At Home Health Care Location: G-8305 South Saginaw, Grand Blanc, Michigan 48439 Ratings: Phone: (810) 606-1946 | |
Absolute Home Health Care Location: 8273 South Saginaw Road, Suite A, Grand Blanc, Michigan 48439 Ratings: Phone: (810) 694-1042 |